KUO-HSING CHENLIANG-IN LINLI-HUI TSENGLin, Yu-LinYu-LinLinJAU-YU LIAUJIA-HUEI TSAIJIN-TUNG LIANGBEEN-REN LINANN-LII CHENGKUN-HUEI YEH2019-11-182019-11-1820190030-2414https://scholars.lib.ntu.edu.tw/handle/123456789/431404We aimed to study the prognostic role of CpG island methylator phenotype (CIMP) in patients with different stages of colorectal cancer (CRC).enCpG island methylator phenotype; Overall survival; Stage IV colorectal cancer[SDGs]SDG3B Raf kinase; BRAF protein, human; KRAS protein, human; protein p21; adult; aged; Article; BRAF V600E gene; cancer mortality; cancer patient; cancer prognosis; cancer staging; cancer survival; clinical feature; colorectal cancer; controlled study; CpG island; CpG island methylator phenotype; DNA methylation; exon; female; gene mutation; hazard ratio; human; major clinical study; male; microsatellite instability; multivariate analysis; oncogene K ras; overall survival; phenotype; prediction; priority journal; very elderly; cancer staging; colorectal tumor; genetics; middle aged; mortality; mutation; pathology; prognosis; survival rate; Aged; Colorectal Neoplasms; CpG Islands; DNA Methylation; Female; Humans; Male; Microsatellite Instability; Middle Aged; Mutation; Neoplasm Staging; Prognosis; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); Survival Ratejournal article10.1159/000493387305409942-s2.0-85058778011WOS:000460986900006https://api.elsevier.com/content/abstract/scopus_id/85058778011